HCTI Fundamental Analysis - HEALTHCARE TRIANGLE INC

Name: HEALTHCARE TRIANGLE INC (HCTI) Stock
Brand: HEALTHCARE TRIANGLE INC
Rating: 3.5 (3 reviews)

Fundamental Rating

Overall HCTI gets a fundamental rating of 2 out of 10. We evaluated HCTI against 35 industry peers in the Health Care Technology industry. HCTI may be in some trouble as it scores bad on both profitability and health. HCTI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HCTI has reported negative net income.

In the past year HCTI has reported a negative cash flow from operations.

HCTI had negative earnings in 4 of the past 5 years.

In the past 5 years HCTI always reported negative operating cash flow.

1.2 Ratios

HCTI has a Return On Assets of -38.89%. This is in the lower half of the industry: HCTI underperforms 65.71% of its industry peers.

HCTI's Return On Equity of -55.49% is on the low side compared to the rest of the industry. HCTI is outperformed by 62.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-38.89%
ROE	-55.49%
ROIC	N/A

ROA(3y)-159.11%

ROA(5y)-96.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HCTI has a worse Gross Margin (15.18%) than 85.71% of its industry peers.

In the last couple of years the Gross Margin of HCTI has grown nicely.

HCTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	15.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.08%

GM growth 5Y3.95%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.

HCTI has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, HCTI has more shares outstanding

HCTI has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.78, we must say that HCTI is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -1.78, HCTI is not doing good in the industry: 65.71% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.04 indicates that HCTI is not too dependend on debt financing.

HCTI's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. HCTI outperforms 54.29% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	-1.78

ROIC/WACCN/A

WACC10.09%

2.3 Liquidity

HCTI has a Current Ratio of 2.81. This indicates that HCTI is financially healthy and has no problem in meeting its short term obligations.

HCTI has a better Current ratio (2.81) than 62.86% of its industry peers.

HCTI has a Quick Ratio of 2.81. This indicates that HCTI is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 2.81, HCTI is in the better half of the industry, outperforming 62.86% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.81
Quick Ratio	2.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.50% over the past year.

Looking at the last year, HCTI shows a very negative growth in Revenue. The Revenue has decreased by -45.90% in the last year.

Measured over the past years, HCTI shows a very negative growth in Revenue. The Revenue has been decreasing by -16.46% on average per year.

EPS 1Y (TTM)74.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.17%

Revenue 1Y (TTM)-45.9%

Revenue growth 3Y-30.78%

Revenue growth 5Y-16.46%

Sales Q2Q%19.24%

3.2 Future

HCTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.69% yearly.

Based on estimates for the next years, HCTI will show a very negative growth in Revenue. The Revenue will decrease by -10.03% on average per year.

EPS Next Y-1422.22%

EPS Next 2Y-66.67%

EPS Next 3Y28.28%

EPS Next 5Y60.69%

Revenue Next Year-68.65%

Revenue Next 2Y-32.54%

Revenue Next 3Y-18.26%

Revenue Next 5Y-10.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCTI. In the last year negative earnings were reported.

Also next year HCTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

HCTI's earnings are expected to grow with 28.28% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-66.67%

EPS Next 3Y28.28%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HCTI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (11/21/2025, 8:00:02 PM)

After market: 1.8802 -0.03 (-1.56%)

1.91

+0.11 (+6.11%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)11-13 2025-11-13/bmo

Earnings (Next)N/A N/A

Inst Owners1.06%

Inst Owner Change-96.04%

Ins Owners0%

Ins Owner Change0%

Market Cap11.21M

Revenue(TTM)11.87M

Net Income(TTM)-5.67M

Analysts82.86

Price Target5.1 (167.02%)

Short Float %12.84%

Short Ratio0.55

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.94
P/FCF	N/A
P/OCF	N/A
P/B	1.1
P/tB	2.49
EV/EBITDA	N/A

EPS(TTM)-157.51

EYN/A

EPS(NY)-0.25

Fwd EYN/A

FCF(TTM)-1.51

FCFYN/A

OCF(TTM)-1.41

OCFYN/A

SpS2.02

BVpS1.74

TBVpS0.77

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-38.89%
ROE	-55.49%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	15.18%
FCFM	N/A

ROA(3y)-159.11%

ROA(5y)-96.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.08%

GM growth 5Y3.95%

F-Score3

Asset Turnover0.81

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.81
Quick Ratio	2.81
Altman-Z	-1.78

F-Score3

WACC10.09%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)74.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.17%

EPS Next Y-1422.22%

EPS Next 2Y-66.67%

EPS Next 3Y28.28%

EPS Next 5Y60.69%

Revenue 1Y (TTM)-45.9%

Revenue growth 3Y-30.78%

Revenue growth 5Y-16.46%

Sales Q2Q%19.24%

Revenue Next Year-68.65%

Revenue Next 2Y-32.54%

Revenue Next 3Y-18.26%

Revenue Next 5Y-10.03%

EBIT growth 1Y54.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-21.3%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-37.45%

OCF growth 3YN/A

OCF growth 5YN/A

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

ChartMill assigns a fundamental rating of 2 / 10 to HCTI.

What is the valuation status of HEALTHCARE TRIANGLE INC (HCTI) stock?

ChartMill assigns a valuation rating of 1 / 10 to HEALTHCARE TRIANGLE INC (HCTI). This can be considered as Overvalued.

How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?

HEALTHCARE TRIANGLE INC (HCTI) has a profitability rating of 1 / 10.

HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

What is the valuation status of HEALTHCARE TRIANGLE INC (HCTI) stock?

How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?